Evidence mapPaperPMID 37299382Full record

Trial reportNutrients2023

Acute Cognitive Performance and Mood Effects of Coffeeberry Extract: A Randomized, Double Blind, Placebo-Controlled Crossover Study in Healthy Humans.

Philippa A Jackson, Charlotte Kenney, Joanne Forster, Ellen F Smith, Rian Elcoate, Bethany Spittlehouse, Jodee Johnson, David O Kennedy

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Philippa A JacksonBrain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.ORCID 0000-0002-9492-134X
Charlotte KenneyBrain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.
Joanne ForsterBrain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.
Ellen F SmithBrain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.
Rian ElcoateBrain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.
Bethany SpittlehouseHealth Research Authority, Holland Drive, Newcastle upon Tyne NE2 4NQ, UK.
Jodee JohnsonPepsiCo, Health & Nutrition Sciences, Chicago, IL 60607, USA.
David O KennedyBrain Performance and Nutrition Research Centre, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.

Funding

PepsiCo PEP-2005
6 · The paper itself

Abstract

backgroundCoffeeberry extract, rich in chlorogenic acids, shows promise in improving mood and cognition, particularly when co-supplemented with phenolic compounds. However, limited work has considered the effects of coffeeberry in isolation, especially at low doses.

objectiveThe current study investigated the effect of low and moderate doses of coffeeberry extract on cognition and mood.

designThis randomized, double-blind, placebo-controlled crossover design investigated three active beverages on a sample of 72 healthy adults aged 18-49 years. The investigational beverages contained 100 mg or 300 mg coffeeberry extract (standardized to 40% chlorogenic acid), or 75 mg caffeine (positive control). Cognition, mood, and subjective energy were measured at baseline and then again at 60 and 120 min post-treatment.

resultsAnalysis revealed no effect of 300 mg coffeeberry extract, while 100 mg resulted in increased mental fatigue during the performance of cognitively demanding tasks (

conclusionsAdministration of 100 mg and 300 mg coffeeberry extracts revealed limited, transient negative effects following 100 mg coffeeberry. Given the large number of outcome measures analysed and the absence of findings following the 300 mg dose, these negative findings should be interpreted with caution. Overall, the findings of the current study suggest that coffeeberry extract at a low or moderate dose does not have a beneficial effect on mood, mental and physical energy levels, or cognition; higher doses, as have been administered previously, may be more effective.

Indexed as

BeveragesCognitionAdultAffectCaffeineChlorogenic AcidCross-Over StudiesDouble-Blind MethodHumansPlant ExtractsCaffeineChlorogenic AcidPlant Extractscoffeeberrycognitionmoodpolyphenols

Identifiers

PMID37299382
PMCPMC10254646

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.